News
-
-
-
-
-
-
-
-
PRESS RELEASE
Launch of a capital increase with an indicative amount of approximately EUR10 million to accelerate commercial development
Fermentalg announces a capital increase of approximately €10 million to accelerate commercial development. Major shareholder Huvepharma and institutional investors show strong support. Price per share: €0.46, 20% discount to reference price -
-